FDA Circular No.2020-007-B || Further Amendment to FDA Circular No. 2020-007 entitled “Guidelines on the Implementation of the Use of Electronic Means of Prescription for Drugs for the Benefit of Individuals Vulnerable to COVID-19”

On 17 March 2020, FDA Circular No. 2020-007 was issued providing guidelines for the implementation of the use of electronic means of prescription for drugs for the benefit of individuals […]